2 December 2014
A new study has found that behavioural and drug interventions to prevent people from developing type 2 diabetes are equally effective on both genders. Regardless of whether the participant was male or female, this early treatment was shown to reduce weight and prevent further progression towards the condition.
Led by Dr Anna Glechner, Danube University Krems, Austria, and Dr Jürgen Harreiter, Medical University of Vienna, Austria, the systematic review and meta-analysis focused on patients in the prediabetes stage.
It is characterised by a person having an intermediate stage between normal blood glucose control (normoglycaemia) and type 2 diabetes (high blood glucose levels/poor control).
Along with colleagues, Dr Glechner analysed 12 studies between 1980 and 2013 that explored sex-specific differences in treatment effects. Compared with usual care, men and women who received lifestyle interventions, including diet and exercise, were 40 per cent less likely to have diabetes a year later and 37 per cent less likely after three years.
Posted by Philip Briggs
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.